| |
|
|
|
Neos Therapeutics  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
1.51 
|
|
High: |
|
Low: |
|
Resistance:
|
1.29
1.68
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
0.67
0.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.12
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
0.93 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.78 |
Stochastic Oscillator |
%K(14,3):
|
64.70 |
|
MA(250): |
0.74 |
%D(3): |
77.69 |
|
Average Volume(K) |
3-Month: |
670712
|
52-Week |
High:
|
1.68 |
|
10-Days: |
1868518 |
Low: |
0.45 |
|
RSI |
RSI(14):
|
64.67 |
Change(%): |
64.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.439 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
49.76 |
|
EPS Est. Current Year |
-3.110 |
Return on Assets (ttm) |
-10.7 |
Shares Float (M) |
44.26 |
|
EPS Est. Next Year |
-1.440 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.50 |
|
EPS Est. Next Quarter |
-0.670 |
Qtrly Rev. Growth |
-28.5 |
% Held by Institutions |
33.38 |
|
Forward EPS |
-0.340 |
Gross Profit (p.s.) |
0.794 |
Shares Short (K) |
1290 |
|
Book Value (p.s.) |
-0.410 |
EBITDA (p.s.) |
-0.195 |
P/E |
-2.62 |
|
Sales Per Share |
1.145 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.80 |
|
Profit Margin |
-38.35 |
Operating Cash Flow
(M) |
-6.41 |
P/S |
1.00 |
|
Operating Margin |
-23.50 |
Levered Free Cash Flow
(M) |
0.81 |
P/CF |
-8.93 |
|
|
|
|
|
|
